William E. Klitgaard - 25 May 2022 Form 4 Insider Report for Syneos Health, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 25 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 May 2022, 17:08:12 UTC
Prior SEC filing: 09 Aug 2021
Next SEC filing: 18 Oct 2022
Source filing: View source filing
Reporting owner signature: /s/ Sara Epstein, Attorney-in-Fact

Key filing fact

William E. Klitgaard filed Form 4 for Syneos Health, Inc. on 27 May 2022.

Key facts

This page summarizes William E. Klitgaard's Form 4 filing for Syneos Health, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 May 2022, 17:08.

Change

Previous filing in this sequence was filed on 09 Aug 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SYNH transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +2,839
Change %: +17%
Price: $0.000000
Shares after: 19,438
Date: 25 May 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of restricted stock units that vests in full one year from the grant date, or, if earlier, the date of the next subsequent annual meeting following the grant date but only to the extent the director is not re-elected as a non-employee director at such annual meeting, in each case, subject to continued service on the Issuer's Board of Directors.